Menu
Back to User profile » Dr Xiaodan Mao
Papers published by Dr Xiaodan Mao:
Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer
Ma J, Lin J, Lin X, Ren Y, Liu D, Tang S, Huang L, Xu S, Mao X, Sun P
Journal of Inflammation Research 2024, 17:2039-2050
Published Date: 2 April 2024
Peripheral Blood Lymphocyte Subsets as a Risk Predictor of Patients with Endometrioid Endometrial Cancer
Su P, An J, Yu L, Lei H, Huang L, Mao X, Sun P
Journal of Inflammation Research 2022, 15:6153-6163
Published Date: 8 November 2022
Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer
Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, Sun P
Journal of Inflammation Research 2021, 14:7131-7142
Published Date: 21 December 2021
Low Red Blood Cell Count as an Early Indicator for Myometrial Invasion in Women with Endometrioid Endometrial Carcinoma with Metabolic Syndrome
Tong Y, Xie X, Mao X, Lei H, Chen Y, Sun P
Cancer Management and Research 2020, 12:10849-10859
Published Date: 29 October 2020
The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
Pan D, Dong B, Gao H, Mao X, Xue H, Sun P
Risk Management and Healthcare Policy 2020, 13:1747-1756
Published Date: 24 September 2020
Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome
He S, Mao X, Lei H, Dong B, Guo D, Zheng B, Sun P
Journal of Inflammation Research 2020, 13:441-450
Published Date: 18 August 2020
Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
Mao X, Dong B, Gao M, Ruan G, Huang M, Braicu EI, Sehouli J, Sun P
OncoTargets and Therapy 2019, 12:6757-6767
Published Date: 20 August 2019
Clinical validation of the Cervista® high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
Mao X, Ruan G, Dong B, Chen L, Xu S, Lin F, Sun P
Therapeutics and Clinical Risk Management 2018, 14:2243-2253
Published Date: 16 November 2018
Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case–control study
Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, Pan D, Lin F
Cancer Management and Research 2018, 10:4839-4851
Published Date: 23 October 2018
Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
Ruan GY, Song YY, Dong BH, Mao XD, Lin F, Kang YF, Xu SX, Chen XJ, Wu QB, Sun PM
Cancer Management and Research 2018, 10:3227-3235
Published Date: 4 September 2018
Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J
Cancer Management and Research 2018, 10:2521-2535
Published Date: 10 August 2018